Accuray announces china national medical products administration approval of the radixact® sync™ and cyberknife® s7™ systems; expands on the china product portfolio that includes the recently approved tomo® c system

Madison, wis. , jan. 13, 2025 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that the company's radixact sync™ system and cyberknife® s7™ system have been approved by the chinese national medical products administration (nmpa).
ARAY Ratings Summary
ARAY Quant Ranking